Monitoring Adverse Events Effectively

And in my experience as a pharmacovigilance specialist, one of the biggest challenges is finding the right tools to effectively monitor adverse events in real-time. Recently, I’ve been using a new software that aggregates data from multiple sources and it’s made a noticeable difference in our response times. I’d love to hear what tools you all are using and any tips for enhancing patient safety in clinical research.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‍​⁠​‌​⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌​‌‍‌‍​‌‌‍⁠‍‌​‍‍​⁠‌‍‌​‌‍‌​​⁠‌‍⁠​‌‌‌‍‌⁠‌‍​⁠‌⁠‌‍⁠⁠‌​‍​​‍⁠‌‌‍‌⁠​‍​‍‌⁠⁠‌​

I get what you’re saying about real-time monitoring — it’s crucial. In my experience, integrating AI tools for data trend analysis significantly improved our ability to catch adverse events earlier. One caveat is that the upfront cost can be steep, so it’s important to weigh the long-term benefits against initial investment.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌⁠​⁠​‍​⁠‌‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠‌‍​⁠​‌​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌‍‌‍‍⁠​‍⁠‌‌​‍‌‌⁠​‌‌⁠‍‌‌⁠​‌‌‌‍​‌​‌​‌⁠‍‍‌⁠‌​‌‌​⁠‌​⁠​​⁠​⁠‌‍‍⁠​⁠‍​​‍​‍‌⁠⁠‌